Grants for Independent school districts - Health

This funding opportunity provides financial support for early-career researchers to explore innovative studies that address the intersection of substance use disorders and HIV/AIDS, helping them transition into independent research careers.

This funding opportunity supports early-career clinician-scientists in pain management research, providing salary and research funding to help them develop independent clinical trials and advance healthcare practices related to pain treatment.

This grant provides funding to strengthen the global public health workforce by enhancing training programs and collaboration among countries to effectively respond to disease outbreaks and public health challenges.

This funding opportunity supports researchers investigating the biological mechanisms behind complex brain disorders, focusing on specific risk factors and their interactions, to advance understanding and potential treatments.

This funding opportunity supports clinical trials aimed at developing and testing new treatments for communication disorders, such as those affecting hearing and speech, with a focus on ensuring they can be integrated into standard medical care.

This funding opportunity supports researchers in expanding their cancer studies to address health disparities affecting racial and ethnic minorities and underserved populations, encouraging collaboration between experienced cancer researchers and those focused on disparities.

This funding opportunity supports research projects that evaluate and improve strategies for preventing teen pregnancy and promoting adolescent health among youth populations.

This funding opportunity provides financial support for institutions to create and manage accessible data archives that enhance neuroscience research by storing and sharing data generated by the BRAIN Initiative and related studies, while promoting inclusivity in research participation.

This funding opportunity supports early stage researchers in pursuing innovative and high-risk scientific projects that significantly diverge from their previous work, without the need for preliminary data.

This funding opportunity supports long-term, investigator-led clinical trials aimed at advancing research in allergy, infectious diseases, and aging, available to a wide range of eligible institutions both in the U.S. and internationally.

The National Institute of Neurological Disorders and Stroke (NINDS), in collaboration with the National Institute of Mental Health (NIMH), intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications that propose the development and early stage validation of novel humanized small animal models and/or human cellular microphysiological systems for NeuroHIV preclinical research. The goal of this initiative is to promote a significant improvement in the translational relevance of NeuroHIV models, specifically in the context of chronic HIV infection of the central nervous system (CNS) in the modern antiretroviral therapy (ART) era under conditions of viral suppression. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Summer 2024 with an expected application due date in Fall 2024. This NOFO will utilize the R61/R33 activity code. Details of the planned NOFO are provided below.

The "Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials" grant is a funding opportunity from the Department of Health and Human Services that invites various organizations to apply for funding to conduct multi-site clinical trials aimed at developing interventions for preventing, delaying, or treating symptoms of Alzheimer’s disease and other age-related dementias.

This funding opportunity is designed to support U.S. organizations with limited NIH funding to conduct innovative research on the ethical, legal, and social implications of advancements in human genetics and genomics, while fostering collaboration with affected communities and developing research capacity.

This funding opportunity supports researchers and institutions developing innovative organ-on-a-chip technologies to advance disease modeling and preclinical studies in dental, oral, and craniofacial health.

The Proposition 47 Request for Proposals (RFP), announced by the Board of State and Community Corrections (BSCC), aims to provide approximately $152 million in grant funding over a period from October 1, 2024, through June 30, 2028. This program aligns with the BSCC's mission to enhance public safety and criminal justice in California by focusing on rehabilitation and community-based solutions, rather than solely incarceration. The grant is designed to support mental health services, substance use disorder treatment, and diversion programs for individuals within the criminal justice system. The primary beneficiaries of this grant are people in the criminal justice system in California who require mental health services, substance use disorder treatment, and/or diversion programs. Eligible applicants are public agencies located within the State of California, including counties, cities, Indian reservations or Rancherias, school districts, municipal corporations, and various other public entities. The overarching impact goal is to reduce recidivism, improve public health outcomes, and foster safer communities by addressing the root causes of criminal behavior. The program prioritizes the provision of mental health services, substance use disorder treatment, and diversion programs. Additionally, applicants are strongly encouraged to offer supplemental housing-related services and other community-based supportive services. These supportive services include job skills training, case management, and civil legal services, which are critical for successful reintegration into society and long-term stability. The grant structure includes two categories: a Small Scope Category, offering up to $2 million per project with $60.8 million available in total, and a Large Scope Category, providing between $2 million and $8 million per project, with $91.2 million in total funds available. The expected outcomes include a measurable increase in access to mental health and substance use disorder treatment, a reduction in the number of individuals entering or re-entering the criminal justice system, and improved rates of employment and stable housing for program participants. The BSCC's strategic priorities, reflected in this RFP, emphasize evidence-based practices and community-driven solutions. The underlying theory of change posits that by investing in comprehensive services that address the social and economic determinants of criminal behavior, individuals can achieve sustained recovery and successful community reintegration, thereby leading to a more just and equitable society.

This funding opportunity provides financial support to local public or nonprofit agencies in Ohio to establish or expand School-Based Health Centers that deliver essential medical, dental, vision, and mental health services to underserved youth directly within school settings.

This funding opportunity provides financial support to a variety of organizations in Senegal to strengthen public health systems and improve responses to infectious disease threats.

This funding opportunity supports projects that improve the competitiveness of California's specialty crops, benefiting a wide range of organizations, including nonprofits, government entities, and educational institutions.

This funding opportunity supports innovative research projects that address urgent issues in substance use and health services, particularly those arising from recent public health crises, and is open to a variety of organizations, including educational institutions and nonprofits.

The NICHD Small Research Grant Program (Clinical Trial Required) supports clinical trials that fall within the NICHD mission. This funding opportunity announcement is for basic science experimental studies involving humans, referred to in NOT-OD-18-212 as prospective basic science studies involving human participants. These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should submit under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind. Studies conducted with specific applications toward processes or products in mind should submit under the appropriate Clinical Trials Required FOA.